{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fcar-t-faq-y_RoZlEK","width":444,"version":"1.0","type":"rich","title":"CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/8ee5d8aa-6fde-4aa5-a4cb-6ad2ff4ec268/asco-car-t-ss-tu-podcasticon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2342c9a9-c70d-4639-8c99-84beda4762d7\" height=\"200\" width=\"100%\" title=\"CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with CAR T-cell therapy."}